Chimerix, Inc. (CMRX) Analysts See $-0.49 EPS; Chipotle Mexican Grill (CMG) Sellers Decreased By 5.32% Their Shorts

February 20, 2018 - By Adrian Erickson

Chipotle Mexican Grill Incorporated (NYSE:CMG) had a decrease of 5.32% in short interest. CMG’s SI was 5.17M shares in February as released by FINRA. Its down 5.32% from 5.46M shares previously. With 1.16M avg volume, 5 days are for Chipotle Mexican Grill Incorporated (NYSE:CMG)’s short sellers to cover CMG’s short positions. The SI to Chipotle Mexican Grill Incorporated’s float is 20.07%. The stock increased 6.62% or $18.98 during the last trading session, reaching $305.63. About 2.74 million shares traded or 104.56% up from the average. Chipotle Mexican Grill, Inc. (NYSE:CMG) has risen 7.62% since February 20, 2017 and is uptrending. It has underperformed by 9.08% the S&P500.

Analysts expect Chimerix, Inc. (NASDAQ:CMRX) to report $-0.49 EPS on March, 1.They anticipate $0.17 EPS change or 53.13% from last quarter’s $-0.32 EPS. After having $-0.37 EPS previously, Chimerix, Inc.’s analysts see 32.43% EPS growth. The stock increased 1.41% or $0.07 during the last trading session, reaching $5.02. About 251,278 shares traded. Chimerix, Inc. (NASDAQ:CMRX) has risen 3.54% since February 20, 2017 and is uptrending. It has underperformed by 13.16% the S&P500.

Investors sentiment increased to 1.08 in Q3 2017. Its up 0.24, from 0.84 in 2017Q2. It is positive, as 12 investors sold Chimerix, Inc. shares while 25 reduced holdings. 8 funds opened positions while 32 raised stakes. 33.85 million shares or 4.32% more from 32.45 million shares in 2017Q2 were reported. Zurcher Kantonalbank (Zurich Cantonalbank), Switzerland-based fund reported 896 shares. Ameritas Ptnrs stated it has 0% in Chimerix, Inc. (NASDAQ:CMRX). Wells Fargo Mn, California-based fund reported 53,326 shares. First Quadrant Ltd Partnership Ca reported 0% stake. Citadel Advsrs Ltd Llc invested in 0% or 165,490 shares. Group One Trading L P reported 4,967 shares. Fmr Ltd Liability Corporation invested in 0% or 7.00M shares. State Board Of Administration Of Florida Retirement Sys holds 0% of its portfolio in Chimerix, Inc. (NASDAQ:CMRX) for 29,098 shares. California Public Employees Retirement System has 0% invested in Chimerix, Inc. (NASDAQ:CMRX) for 77,200 shares. Moreover, Bnp Paribas Arbitrage Sa has 0% invested in Chimerix, Inc. (NASDAQ:CMRX). California-based Leisure Management has invested 0.13% in Chimerix, Inc. (NASDAQ:CMRX). Artal Group Inc Sa has invested 0.05% in Chimerix, Inc. (NASDAQ:CMRX). Panagora Asset accumulated 208,549 shares. Blackrock accumulated 2.93M shares or 0% of the stock. Prescott Grp Incorporated Cap Mgmt Limited Co invested in 0.27% or 252,811 shares.

Among 10 analysts covering Chimerix Inc (NASDAQ:CMRX), 3 have Buy rating, 3 Sell and 4 Hold. Therefore 30% are positive. Chimerix Inc had 20 analyst reports since August 5, 2015 according to SRatingsIntel. The company was initiated on Thursday, December 17 by UBS. FBR Capital maintained Chimerix, Inc. (NASDAQ:CMRX) on Tuesday, February 23 with “Mkt Perform” rating. The stock of Chimerix, Inc. (NASDAQ:CMRX) earned “Hold” rating by Cowen & Co on Monday, August 7. FBR Capital initiated the shares of CMRX in report on Tuesday, August 18 with “Outperform” rating. The stock has “Overweight” rating by Piper Jaffray on Monday, December 28. The company was downgraded on Monday, October 5 by Morgan Stanley. The stock of Chimerix, Inc. (NASDAQ:CMRX) earned “Mkt Perform” rating by FBR Capital on Monday, December 28. The firm has “Buy” rating given on Thursday, August 6 by Brean Capital. The firm has “Overweight” rating given on Tuesday, December 29 by Barclays Capital. The stock of Chimerix, Inc. (NASDAQ:CMRX) has “Buy” rating given on Thursday, September 3 by Citigroup.

Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines that address unmet medical needs in the United States. The company has market cap of $236.58 million. The company's lead product candidate is brincidofovir, an investigational nucleoside analog for the prevention of serious viral infections in hematopoietic or stem cell transplant recipients , as well as for the treatment of serious adenovirus infection and disease, smallpox, and BK virus infection in kidney and HCT transplant recipients. It currently has negative earnings. It is also developing CMX521, a nucleoside analog that is in preclinical stage for the treatment and prevention of norovirus; and CMX157, a nucleoside analog, which is in Phase II clinical stage to treat HIV and hepatitis B virus infection.

Since February 15, 2018, it had 1 insider purchase, and 0 insider sales for $145,440 activity. On Thursday, February 15 CAPPUCCIO PAUL T bought $145,440 worth of Chipotle Mexican Grill, Inc. (NYSE:CMG) or 500 shares.

Among 44 analysts covering Chipotle Mexican Grill Inc. (NYSE:CMG), 10 have Buy rating, 6 Sell and 28 Hold. Therefore 23% are positive. Chipotle Mexican Grill Inc. had 236 analyst reports since July 22, 2015 according to SRatingsIntel. Maxim Group maintained the shares of CMG in report on Wednesday, February 3 with “Hold” rating. The firm has “Hold” rating given on Wednesday, July 26 by Jefferies. The rating was maintained by Telsey Advisory Group with “Outperform” on Monday, December 7. The rating was maintained by Nomura with “Neutral” on Tuesday, January 30. The firm has “Overweight” rating given on Thursday, April 14 by JP Morgan. The company was maintained on Monday, June 5 by Wedbush. The firm has “Neutral” rating by Mizuho given on Wednesday, February 7. The firm earned “Sell” rating on Wednesday, April 27 by Maxim Group. The firm has “Hold” rating given on Wednesday, August 26 by Vetr. The firm has “Neutral” rating given on Tuesday, June 20 by Credit Suisse.

Chipotle Mexican Grill, Inc., together with its subsidiaries, develops and operates Chipotle Mexican Grill restaurants. The company has market cap of $8.54 billion. As of December 31, 2016, the firm operated 2,198 Chipotle restaurants throughout the United States, as well as 29 international Chipotle restaurants; and 23 restaurants with non-Chipotle concepts. It has a 49.53 P/E ratio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.